Crossref Citations
This article has been cited by the following publications. This list is generated based on data provided by
Crossref.
Dawson, Gerard R.
Collinson, Neil
and
Atack, John R.
2005.
Development of Subtype Selective GABAAModulators.
CNS Spectrums,
Vol. 10,
Issue. 1,
p.
21.
Yin, Wenyuan
Sarma, P.V.V. Srirama
Ma, Jun
Han, Dongmei
Chen, Jessica L.
and
Cook, James M.
2005.
Synthesis of bivalent ligands of β-carboline-3-carboxylates via a palladium-catalyzed homocoupling process.
Tetrahedron Letters,
Vol. 46,
Issue. 37,
p.
6363.
Ondo, William G.
and
Silay, Yavuz S.
2006.
Intravenous flumazenil for Parkinson's disease: A single dose, double blind, placebo controlled, cross‐over trial.
Movement Disorders,
Vol. 21,
Issue. 10,
p.
1614.
Grunwald, Christian
Rundfeldt, Chris
Lankau, Hans-Joachim
Arnold, Thomas
Höfgen, Norbert
Dost, Rita
Egerland, Ute
Hofmann, Hans-Jörg
and
Unverferth, Klaus
2006.
Synthesis, Pharmacology, and Structure−Activity Relationships of Novel Imidazolones and Pyrrolones as Modulators of GABAAReceptors.
Journal of Medicinal Chemistry,
Vol. 49,
Issue. 6,
p.
1855.
Mirza, N. R.
Rodgers, R. J.
and
Mathiasen, L. S.
2006.
Comparative Cue Generalization Profiles of L-838, 417, SL651498, Zolpidem, CL218,872, Ocinaplon, Bretazenil, Zopiclone, and Various Benzodiazepines in Chlordiazepoxide and Zolpidem Drug Discrimination.
Journal of Pharmacology and Experimental Therapeutics,
Vol. 316,
Issue. 3,
p.
1291.
Mishra, Bikash K
Wu, Tianxia
Belfer, Inna
Hodgkinson, Colin A
Cohen, Leonardo G
Kiselycznyk, Carly
Kingman, Albert
Keller, Robert B
Yuan, Qiaoping
Goldman, David
Atlas, Steven J
and
Max, Mitchell B
2007.
Do Motor Control Genes Contribute to Interindividual Variability in Decreased Movement in Patients with Pain?.
Molecular Pain,
Vol. 3,
Issue. ,
p.
1744-8069-3-20.
June, Harry L.
and
Eiler, William J. A.
2007.
Handbook of Contemporary Neuropharmacology.
Uhde, Thomas W.
and
Cortese, Bernadette M.
2008.
Anxiety In Health Behaviors And Physical Illness.
p.
105.
Georgopoulos, Panagiotis
Petrides, Theodoros
Kostopoulos, George
and
Papatheodoropoulos, Costas
2008.
Varying magnitude of GABAergic recurrent inhibition enhancement by different sedative/anesthetic agents in dorsal and ventral hippocampus.
Brain Research,
Vol. 1207,
Issue. ,
p.
43.
Kohut, Stephen J.
and
Ator, Nancy A.
2008.
Novel discriminative stimulus effects of TPA023B, subtype-selective γ-aminobutyric-acidA/benzodiazepine modulator: Comparisons with zolpidem, lorazepam, and TPA023.
Pharmacology Biochemistry and Behavior,
Vol. 90,
Issue. 1,
p.
65.
Neubauer, David
2008.
New Directions in the Pharmacologic Treatment of Insomnia.
CNS Spectrums,
Vol. 13,
Issue. S17,
p.
10.
Morrow, Eric M.
Roffman, Joshua L.
Wolf, Daniel H.
and
Coyle, Joseph T.
2008.
Massachusetts General Hospital Comprehensive Clinical Psychiatry.
p.
543.
Rowlett, James K.
2008.
Handbook of Anxiety and Fear.
Vol. 17,
Issue. ,
p.
223.
Mirza, N. R.
Larsen, J. S.
Mathiasen, C.
Jacobsen, T. A.
Munro, G.
Erichsen, H. K.
Nielsen, A. N.
Troelsen, K. B.
Nielsen, E. Ø.
and
Ahring, P. K.
2008.
NS11394 [3′-[5-(1-Hydroxy-1-methyl-ethyl)-benzoimidazol-1-yl]-biphenyl-2-carbonitrile], a Unique Subtype-Selective GABAA Receptor Positive Allosteric Modulator: In Vitro Actions, Pharmacokinetic Properties and in Vivo Anxiolytic Efficacy.
Journal of Pharmacology and Experimental Therapeutics,
Vol. 327,
Issue. 3,
p.
954.
Licata, Stephanie C.
Platt, Donna M.
Cook, James M.
Van Linn, Michael L.
and
Rowlett, James K.
2009.
Contribution of α1 subunit-containing γ-aminobutyric acidA (GABAA) receptors to motor-impairing effects of benzodiazepines in squirrel monkeys.
Psychopharmacology,
Vol. 203,
Issue. 3,
p.
539.
Chen, Xuebin
Cromer, Brett A.
and
Lynch, Joseph W.
2009.
Molecular determinants of β‐carboline inhibition of the glycine receptor.
Journal of Neurochemistry,
Vol. 110,
Issue. 5,
p.
1685.
Yin, Wenyuan
Majumder, Samarpan
Clayton, Terry
Petrou, Steven
VanLinn, Michael L.
Namjoshi, Ojas A.
Ma, Chunrong
Cromer, Brett A.
Roth, Bryan L.
Platt, Donna M.
and
Cook, James M.
2010.
Design, synthesis, and subtype selectivity of 3,6-disubstituted β-carbolines at Bz/GABA(A)ergic receptors. SAR and studies directed toward agents for treatment of alcohol abuse.
Bioorganic & Medicinal Chemistry,
Vol. 18,
Issue. 21,
p.
7548.
Williams, Larry R.
Aroniadou-Anderjaska, Vassiliki
Qashu, Felicia
Finne, Huckelberry
Pidoplichko, Volodymyr
Bannon, Desmond I.
and
Braga, Maria F. M.
2011.
RDX Binds to the GABA
A
Receptor–Convulsant Site and Blocks GABA
A
Receptor–Mediated Currents in the Amygdala: A Mechanism for RDX-Induced Seizures
.
Environmental Health Perspectives,
Vol. 119,
Issue. 3,
p.
357.
Zhou, Diansong
Sunzel, Maria
Ribadeneira, Maria D.
Smith, Mark A.
Desai, Dhaval
Lin, Jianrong
and
Grimm, Scott W.
2012.
A clinical study to assess CYP1A2 and CYP3A4 induction by AZD7325, a selective GABAA receptor modulator – an in vitro and in vivo comparison.
British Journal of Clinical Pharmacology,
Vol. 74,
Issue. 1,
p.
98.
Joksimović, Srđan
Varagic, Zdravko
Kovačević, Jovana
Van Linn, Michael
Milić, Marija
Rallapalli, Sundari
Timić, Tamara
Sieghart, Werner
Cook, James M.
and
Savić, Miroslav M.
2013.
Insights into functional pharmacology of α1 GABAA receptors: how much does partial activation at the benzodiazepine site matter?.
Psychopharmacology,
Vol. 230,
Issue. 1,
p.
113.